Clinical trials
Phase 1/2 Recurrence trials in Japan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 4 |
| 2024 | 2 |
| 2025 | 4 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 6 |
| Terminated | 5 |
| Active, not recruiting | 4 |
| Not yet recruiting | 2 |
| Completed | 1 |
| Suspended | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 2 |
| AstraZeneca | 2 |
| Celgene | 2 |
| GlaxoSmithKline | 2 |
| Pfizer | 2 |
| Bristol-Myers Squibb | 1 |
| Daiichi Sankyo | 1 |
| Jichi Medical University | 1 |
| Mundipharma K.K. | 1 |
| Nanjing IASO Biotechnology Co., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Recurrence | 20 |
| Lymphoma | 6 |
| Multiple Myeloma | 6 |
| Lymphoma, Large B-Cell, Diffuse | 4 |
| Lymphoma, Non-Hodgkin | 3 |
| Burkitt Lymphoma | 2 |
| Immunoblastic Lymphadenopathy | 2 |
| Leukemia, Myeloid, Acute | 2 |
| Leukemia-Lymphoma, Adult T-Cell | 2 |
| Lymphoma, B-Cell | 2 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.